| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702311 | Surgical Oncology | 2017 | 5 Pages |
Abstract
The findings extend prior reports on the role of FDG-PET/CT in the management of recurrent ovarian cancer, to the prediction of secondary optimal debulking. Future studies should aim to investigate the impact on survival.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Amnon Amit, Adina Hodes, Ofer Lavie, Zohar Keidar, Emad Matanes, Lior Lowenstein,